Abstract
The coronavirus disease-2019 (COVID-19) pandemic has rapidly spread
across the world. The disease is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan,
China in December, 2019. Ever increasing data is emerging about COVID-19
and its effects on the arterial and venous circulation. Clinical
features associated with COVID-19 suggest that endothelial cell
dysfunction and microvascular thrombosis are to a large part
contributing to resultant multi-organ complications. This review is
aimed at highlighting the critical aspects associated with COVID-19 and
its presumed microvascular angiopathic complications leading to
multi-organ dysfunction.